NASSER TAGHAVI: Open Payments
NPI 1487624383 · LIVONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$547 in 26 payments from 12 companies in 2025. Trend: 2023 $1,335 · 2024 $682 · 2025 $547
Food & beverage: $547
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 6 | $139 |
| ABBVIE INC. | 3 | $73 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Neurocrine BioSciences, Inc. | 2 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $29 |
| Orexo US, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $20 |
| Abbott Laboratories | 1 | $19 |
Products named: SUBLOCADE, VRAYLAR, FARXIGA, INGREZZA, CAPLYTA, AUSTEDO XR, JARDIANCE, Zubsolv.
Industry payments across MI — which companies pay providers there.
